1/8
01:30 am
ogn
Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo® in France, Denmark, Iceland, Sweden, Finland and Norway
Low
Report
Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo® in France, Denmark, Iceland, Sweden, Finland and Norway
1/3
01:08 am
ogn
Low
Report
12/10
07:18 am
ogn
Organon & Co. (NYSE:OGN) was upgraded by analysts at Barclays PLC to a "strong sell" rating.
Medium
Report
Organon & Co. (NYSE:OGN) was upgraded by analysts at Barclays PLC to a "strong sell" rating.
12/9
09:06 am
ogn
Organon & Co. (NYSE:OGN) is now covered by analysts at Barclays PLC. They set an "underweight" rating and a $7.50 price target on the stock.
Medium
Report
Organon & Co. (NYSE:OGN) is now covered by analysts at Barclays PLC. They set an "underweight" rating and a $7.50 price target on the stock.
12/1
10:24 am
ogn
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know [Yahoo! Finance]
Low
Report
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know [Yahoo! Finance]
11/25
07:30 am
ogn
Organon To Present at the Piper Sandler 37th Annual Healthcare Conference
Medium
Report
Organon To Present at the Piper Sandler 37th Annual Healthcare Conference
11/17
09:06 am
ogn
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US
Low
Report
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US
11/17
05:30 am
ogn
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US
Low
Report
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US
11/10/2025
07:30 am
ogn
organon & co.
BEAT
Report
10.6%
organon & co.
8/5/2025
07:30 am
ogn
organon & co.
BEAT
Report
-18.4%
organon & co.
5/1/2025
07:00 am
ogn
organon & co.
BEAT
Report
-21.3%
organon & co.
2/13/2025
07:30 am
ogn
organon & co.
BEAT
Report
8.1%
organon & co.
11/17
04:05 pm
ogn
Form 4 Organon & Co. For: Nov 13 Filed by: Drinane Juliana Papa
Low
Report
Form 4 Organon & Co. For: Nov 13 Filed by: Drinane Juliana Papa
11/17
04:04 pm
ogn
Form 4 Organon & Co. For: Nov 13 Filed by: Morrissey Joseph T. Jr.
Low
Report
Form 4 Organon & Co. For: Nov 13 Filed by: Morrissey Joseph T. Jr.
11/12
05:49 pm
ogn
Form 4 Organon & Co. For: Nov 07 Filed by: Drinane Juliana Papa
Low
Report
Form 4 Organon & Co. For: Nov 07 Filed by: Drinane Juliana Papa
11/12
05:47 pm
ogn
Form 3 Organon & Co. For: Oct 27 Filed by: Drinane Juliana Papa
Low
Report
Form 3 Organon & Co. For: Oct 27 Filed by: Drinane Juliana Papa
11/10
04:14 pm
ogn
Form 4 Organon & Co. For: Nov 07 Filed by: Arjona Ferreira Juan Camilo
Medium
Report
Form 4 Organon & Co. For: Nov 07 Filed by: Arjona Ferreira Juan Camilo
11/10
04:05 pm
ogn
Form 4 Organon & Co. For: Nov 07 Filed by: Holzbaur Lynette
Low
Report
Form 4 Organon & Co. For: Nov 07 Filed by: Holzbaur Lynette
11/10
08:08 am
ogn
Form 10-Q Organon & Co. For: Sep 30
High
Report
Form 10-Q Organon & Co. For: Sep 30
11/10
07:35 am
ogn
Form 8-K Organon & Co. For: Nov 10
High
Report
Form 8-K Organon & Co. For: Nov 10
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register